COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1554: Articles 15531-15540  | Next

Rapid detection of SARS CoV-2 N501Y mutation in clinical samples
Al-Jaf, S. M. A., Niranji, S. S.
10.1101/2021.04.17.21255656 — Posted: 2021-04-20
COVID-19 Vaccine Prioritisation in Japan and South Korea
Chun, J. Y., Jeong, H., Beutels, P., Ohmagari, N., Kim, Y., Tsuzuki, S.
10.1101/2021.04.16.21255649 — Posted: 2021-04-20
Modelling COVID-19 evolution in Italy with an augmented SIRD model using open data
Nardelli, V., Arbia, G., Palladino, A., Atzeni, L. G.
10.1101/2021.04.14.21255500 — Posted: 2021-04-20
Vaccines, social measures and Covid19 - A European evidence-based analysis
Porter, J. R.
10.1101/2021.04.15.21255558 — Posted: 2021-04-20
The risk of symptomatic reinfection during the second COVID-19 wave in individuals previously exposed to SARS-CoV-2
Manica, M., Pancheri, S., Poletti, P., Giovanazzi, G., Guzzetta, G., Trentini, F., Marziano, V., Ajelli, M., Zuccali, M. G., Benetollo, P. P., Merler, S., Ferro, A.
10.1101/2021.04.14.21255502 — Posted: 2021-04-20
The relationship between human mobility measures and SAR-Cov-2 transmission varies by epidemic phase and urbanicity: results from the United States
Kishore, N., Taylor, A. R., Jacob, P. E., Vembar, N., Cohen, T., Menzies, N. A., Buckee, C.
10.1101/2021.04.15.21255562 — Posted: 2021-04-20
Emergence of the SARS-CoV-2 B.1.1.7 lineage and its characteristics at an outpatient testing site in Berlin, Germany, January-March 2021
van Loon, W., Rössig, H., Burock, S., Hofmann, J., Bernhard, J., Linzbach, E., Pettenkofer, D., Schönfeld, C., Gertler, M., Seybold, J., Kurth, T., Mockenhaupt, F. P.
10.1101/2021.04.15.21255389 — Posted: 2021-04-20
Survival analysis methods for analysis of hospitalization data: Application to COVID-19 patient hospitalization experience
Rathouz, P. J., Valencia, V., Chang, P., Morton, D., Yang, H., Surer, O., Fox, S. J., Meyers, L. A., Matsui, E. C., Haynes, A. B.
10.1101/2021.04.14.21255511 — Posted: 2021-04-20
On whether therapeutic plasma exchange is an effective cure for severe/critical COVID-19 pneumonia
Cegolon, L., Einollahi, B., Imanizadeh, S., Rezapour, M., Javanbakht, M., Nikpouraghdam, M., Abolghasemi, H., Mastrangelo, G.
10.1101/2021.04.19.21255657 — Posted: 2021-04-20
Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting
L'Huillier, A., Lacour, M., Sadiku, D., Gadiri, M. A., De Siebenthal, L., Schibler, M., Eckerle, I., Pinosch, S., Kaiser, L., Gervaix, A., Glangetas, A., Galetto-Lacour, A., Lacroix, L.
10.1101/2021.04.15.21255577 — Posted: 2021-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).